STAT+: Epic’s alleged anticompetitive practices under scrutiny from federal, state investigators
Reported by STAT News · all stories from statnews.com
Editorial digest
Epic Systems is reportedly under scrutiny from both federal and state investigators regarding its alleged anticompetitive business practices and the use of non-disclosure agreements.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/25/2026
STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM
The FDA will issue new AI regulations; Epic's user meeting also had significant updates.
- Trusted health newsroom9/9/2026
STAT+: U.K. unveils recommendations for regulating AI in medicine
The U.K. has published guidelines for regulating AI in medical applications.
- Trusted health newsroom9/14/2026
STAT+: How $500 explains Republican health policy, and the GLP-1 Rx wave
A specific financial figure illuminates Republican health policy and the rise of GLP-1 prescriptions.
- Trusted health newsroom9/15/2026
STAT+: Medicare’s AI prior authorization pilot was rushed and full of problems, new documents reveal
Medicare's AI prior authorization program faced issues and was launched too quickly, according to new details.
- Trusted health newsroom9/9/2026
STAT+: ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure
ARPA-H plans to invest $62 million in FDA-authorized AI for heart failure treatment.
- Trusted health newsroom9/3/2026
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
FDA pilot program allows generative AI devices to reach patients pre-authorization.